What Chronic Inflammation Is Actually Doing to Your Body — and Why It Accelerates Ageing
Inflammation is supposed to be a short-term response that protects you from injury and infection. When it becomes permanent and systemic, it starts destroying the very things it was designed to protect — including your skin, your hormones, and your lifespan.
Acute inflammation is one of biology’s most elegant defensive systems. Cut your finger, and within minutes the area becomes red, warm, swollen, and tender — white blood cells flood the area, pathogens are killed, damaged tissue is cleared, and healing begins. Within days, inflammation resolves and tissue repairs. This is exactly how it should work.
Chronic low-grade inflammation — sometimes called inflammaging — is the opposite of elegant. It is a smouldering, sub-threshold fire that never extinguishes. It does not produce obvious symptoms like fever or swelling. It does not resolve. It silently damages nearly every system in the body over years and decades. And it is now understood as one of the primary drivers of accelerated biological ageing.
The Biology of Inflammaging
Acute inflammation is orchestrated by the innate immune system responding to a specific threat — injury, infection, foreign material. It has a clear on/off switch. Inflammaging lacks this switch. It is driven by persistent, low-level activation of NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells), a master transcription factor that controls the expression of hundreds of inflammatory genes.
When NF-kB is chronically active, cells continuously produce inflammatory cytokines:
- TNF-alpha: Directly activates MMPs that break down collagen; promotes insulin resistance; damages blood vessel walls
- IL-6: Promotes CRP production; accelerates telomere shortening; disrupts leptin signalling; impairs muscle protein synthesis
- IL-1beta: Activates collagenase; promotes cartilage degradation; stimulates fever when acutely elevated but at low levels drives chronic tissue damage
- CRP (C-Reactive Protein): A marker of systemic inflammation measured in blood — a clinical indicator of inflammaging burden
Key drivers of chronic low-grade inflammation: (1) Visceral fat — the most potent inflammatory organ in the body, secreting TNF-alpha, IL-6, and resistin continuously; (2) Gut dysbiosis — imbalanced gut microbiome allows lipopolysaccharide (LPS) from bacterial cell walls to cross into bloodstream, triggering systemic inflammation; (3) Advanced Glycation End-products (AGEs) — bind to RAGE receptors and activate NF-kB; (4) Senescent cells — aged cells that stop dividing but secrete SASP (Senescence-Associated Secretory Phenotype) — a cocktail of inflammatory factors; (5) Poor sleep — inflammatory cytokines that would normally be cleared during sleep accumulate.
How Chronic Inflammation Ages Skin
The skin is one of the most visible targets of inflammaging:
- TNF-alpha and IL-1beta activate collagenase (MMP-1), dramatically increasing collagen breakdown rate
- Inflammatory cytokines impair fibroblast function — cells shift from collagen synthesis to inflammatory signalling
- Reactive oxygen species generated by inflammatory cells damage DNA, cell membranes, and mitochondria in skin cells
- Inflammatory signals trigger melanocyte hyperreactivity, causing post-inflammatory hyperpigmentation
- Chronic inflammation impairs the skin barrier — reduced ceramide production, increased TEWL, greater reactivity to irritants
The result is clinically visible: skin that ages faster than expected for a person’s chronological age, with disproportionate collagen loss, increased pigmentation, barrier dysfunction, and chronic low-grade redness.
When I see a 38-year-old whose skin looks 50, the question I ask is not what skincare they are missing — it is what their CRP level is, what their visceral fat is, how they are sleeping, and what they are eating. The skin is reflecting an internal fire.
Dr. Dinesh Kumar, MBBS, LCP-Certified — Vivardi Clinics Rawang
How Inflammaging Affects Other Systems
Hair Loss
Chronic scalp inflammation is increasingly recognised as a contributing factor in androgenetic alopecia — inflammatory infiltrates around follicle bulges contribute to the progressive miniaturisation and fibrosis. Inflammaging-driven DHT sensitivity may be amplified by inflammatory signalling at the follicle level.
Hormonal Health
IL-6 and TNF-alpha directly impair Leydig cell function in the testes, reducing testosterone production. Inflammatory cytokines increase aromatase activity, converting more testosterone to oestrogen. Chronic inflammation is independently associated with lower testosterone levels in men, partially explaining the co-occurrence of obesity, inflammation, and hypogonadism.
Insulin Resistance
TNF-alpha directly impairs insulin receptor signalling in muscle and liver cells, contributing to insulin resistance. Visceral fat inflammation and insulin resistance exist in a mutually amplifying loop — each worsens the other.
Clinical Approaches That Address Inflammaging
Evidence-Based Anti-Inflammatory Lifestyle Interventions
- Mediterranean-pattern diet: Consistently associated with lower CRP, IL-6, and TNF-alpha. Key elements: olive oil, fatty fish, colourful vegetables, legumes, reduced ultra-processed foods
- Omega-3 supplementation: EPA and DHA are precursors to resolvins and protectins — molecules that actively resolve inflammation. Best evidence from fish oil at 2-4g EPA+DHA daily
- Resistance and aerobic exercise: Reduces visceral fat (eliminating the primary inflammatory organ), reduces CRP, and upregulates anti-inflammatory cytokines. The anti-inflammatory effect of regular exercise is one of the most robust findings in preventive medicine
- Time-restricted eating: Some evidence for autophagy induction during fasting periods, which helps clear senescent cells and reduce inflammatory debris
- Curcumin: Inhibits NF-kB directly — reasonable evidence for anti-inflammatory effect. Bioavailability is poor without piperine (black pepper extract). Food source: turmeric in curry is insufficient; supplementation is needed for therapeutic effect
Frequently Asked Questions
Senescent Cells: The Biological Rubbish That Drives Inflammaging
As cells accumulate DNA damage and reach the limits of their replication capacity, they enter a state called cellular senescence — they stop dividing but do not die. Instead, they remain metabolically active and secrete a cocktail of inflammatory molecules called the Senescence-Associated Secretory Phenotype (SASP): TNF-alpha, IL-6, IL-1beta, proteases, and growth factors that collectively inflame the surrounding tissue.
In youth, senescent cells are efficiently cleared by the immune system (a process called immunosurveillance). As we age, clearance becomes less efficient, and senescent cells accumulate — particularly in chronically inflamed or UV-damaged tissues like skin. Each senescent cell acts as a continuous local source of inflammatory signals, damaging neighbouring cells and impairing tissue function. Skin with a high senescent cell burden shows characteristic features: reduced collagen synthesis, impaired wound healing, chronic low-grade redness, and loss of the regenerative capacity that characterises young skin.
Senolytics — compounds that selectively eliminate senescent cells — are an active frontier of anti-ageing research. Quercetin and dasatinib have shown senolytic effects in early trials. More accessible are interventions that prevent senescence accumulation: reducing UV exposure, managing chronic inflammation, optimising sleep, and maintaining telomere health through NAD+-boosting interventions like NMN therapy.
The Gut Microbiome as a Driver of Systemic Inflammaging
The gut microbiome and inflammaging are deeply interconnected. A diverse, balanced gut microbiome produces anti-inflammatory short-chain fatty acids (butyrate, propionate) that maintain intestinal barrier integrity and suppress NF-kB inflammatory signalling systemically. Gut dysbiosis — reduced microbiome diversity, increased pathogenic species — allows bacterial lipopolysaccharide (LPS) to translocate through a leaky gut into the bloodstream, triggering systemic TLR4-mediated inflammation.
Age-related gut microbiome changes — reduced Lactobacillus and Bifidobacterium populations, increased pathogenic Proteobacteria — contribute directly to inflammaging. This creates a bidirectional relationship: inflammaging damages the gut lining (increasing leakiness), which worsens dysbiosis, which produces more LPS-driven systemic inflammation. Interventions that restore gut microbiome diversity — dietary fibre, fermented foods, probiotic supplementation, reduced antibiotic use — address one of the most modifiable drivers of systemic inflammaging in Malaysian patients.
Measuring Inflammaging: Clinical Markers Worth Knowing
Inflammaging can be objectively monitored through blood tests that measure systemic inflammatory burden:
- High-sensitivity CRP (hsCRP): Most accessible inflammaging marker. Optimal: below 1 mg/L. Above 3 mg/L indicates high cardiovascular and systemic inflammatory risk. Values 1–3 mg/L are intermediate risk.
- IL-6: A direct cytokine marker of inflammaging. Elevated in obesity, visceral fat accumulation, and chronic stress. More specific than CRP but less routinely measured.
- Ferritin: An acute phase reactant that rises with inflammation. High ferritin (above 300 ng/mL in men, 200 in women) can indicate inflammatory burden as well as iron overload.
- Waist circumference: The simplest clinical indicator of visceral fat-driven inflammaging. Above 90cm in Asian men or 80cm in Asian women signals significant risk.
